3 Stocks Moving The Retail Industry Upward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices traded up today with the Dow Jones Industrial Average ( ^DJI) trading up 154 points (0.9%) at 17,210 as of Wednesday, Sept. 24, 2014, 4:20 PM ET. The NYSE advances/declines ratio sits at 1,794 issues advancing vs. 1,244 declining with 169 unchanged.

The Retail industry as a whole closed the day up 0.5% versus the S&P 500, which was up 0.8%. Top gainers within the Retail industry included Gaiam ( GAIA), up 3.6%, Cache ( CACH), up 2.3%, Liberator Medical Holdings ( LBMH), up 4.4%, Citi Trends ( CTRN), up 1.6% and Stamps.com ( STMP), up 2.5%.

TheStreet Ratings Group would like to highlight 3 stocks pushing the industry higher today:

Liberator Medical Holdings ( LBMH) is one of the companies that pushed the Retail industry higher today. Liberator Medical Holdings was up $0.12 (4.4%) to $2.91 on average volume. Throughout the day, 180,513 shares of Liberator Medical Holdings exchanged hands as compared to its average daily volume of 203,300 shares. The stock ranged in a price between $2.80-$2.94 after having opened the day at $2.94 as compared to the previous trading day's close of $2.79.

Liberator Medical Holdings, Inc., together with its subsidiaries, distributes direct-to-consumer durable medical supplies for seniors and others with chronic illness in the United States. Liberator Medical Holdings has a market cap of $156.3 million and is part of the services sector. Shares are down 29.3% year-to-date as of the close of trading on Tuesday. Currently there is 1 analyst who rates Liberator Medical Holdings a buy, no analysts rate it a sell, and none rate it a hold.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

TheStreet Ratings rates Liberator Medical Holdings as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company shows weak operating cash flow.

Highlights from TheStreet Ratings analysis on LBMH go as follows:

  • LBMH's revenue growth has slightly outpaced the industry average of 3.2%. Since the same quarter one year prior, revenues slightly increased by 6.2%. This growth in revenue does not appear to have trickled down to the company's bottom line, displaying stagnant earnings per share.
  • LBMH's debt-to-equity ratio is very low at 0.05 and is currently below that of the industry average, implying that there has been very successful management of debt levels. To add to this, LBMH has a quick ratio of 2.21, which demonstrates the ability of the company to cover short-term liquidity needs.
  • Current return on equity exceeded its ROE from the same quarter one year prior. This is a clear sign of strength within the company. When compared to other companies in the Food & Staples Retailing industry and the overall market, LIBERATOR MEDICAL HLDGS INC's return on equity exceeds that of the industry average and significantly exceeds that of the S&P 500.
  • The gross profit margin for LIBERATOR MEDICAL HLDGS INC is rather high; currently it is at 63.25%. It has increased from the same quarter the previous year. Along with this, the net profit margin of 10.67% is above that of the industry average.
  • Compared to its closing price of one year ago, LBMH's share price has jumped by 28.15%, exceeding the performance of the broader market during that same time frame. Looking ahead, the stock's sharp rise over the last year has already helped drive it to a level which is relatively expensive compared to the rest of its industry. We feel, however, that other strengths this company displays justify these higher price levels.

You can view the full analysis from the report here: Liberator Medical Holdings Ratings Report

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you liked this article you might like

Insider Trading Alert - LBMH, IPWR And KRO Traded By Insiders

Liberator Medical (LBMH) Stock Soars on C. R. Bard Acquisition

Insider Trading Alert - SPH, LBMH And EXPO Traded By Insiders

Insider Trading Alert - TEX, LBMH And PRXL Traded By Insiders

3 Retail Stocks Driving The Industry Higher